Evidence map›Paper›PMID 34183023›Full record

ReviewJournal of nanobiotechnology2021

Chemodynamic nanomaterials for cancer theranostics.

Jingqi Xin, Caiting Deng, Omer Aras, Mengjiao Zhou, Chunsheng Wu, Feifei An

Open access · goldAbstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jingqi XinInstitute of Medical Engineering, Department of Biophysics, School of Basic Medical Science, Health Science Center, Xi'an Jiaotong University, No. 76 Yanta West Road, Xi'an, Shaanxi, 710061, People's Republic of China.
Caiting DengInstitute of Medical Engineering, Department of Biophysics, School of Basic Medical Science, Health Science Center, Xi'an Jiaotong University, No. 76 Yanta West Road, Xi'an, Shaanxi, 710061, People's Republic of China.
Omer ArasDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Mengjiao ZhouDepartment of Pharmacology, School of Pharmacy, Nantong University, 226000, Nantong, Jiangsu, People's Republic of China. mjzhou0207@163.com.
Chunsheng WuInstitute of Medical Engineering, Department of Biophysics, School of Basic Medical Science, Health Science Center, Xi'an Jiaotong University, No. 76 Yanta West Road, Xi'an, Shaanxi, 710061, People's Republic of China. wuchunsheng@xjtu.edu.cn.
Feifei AnInstitute of Medical Engineering, Department of Biophysics, School of Basic Medical Science, Health Science Center, Xi'an Jiaotong University, No. 76 Yanta West Road, Xi'an, Shaanxi, 710061, People's Republic of China. anfeifei@xjtu.edu.cn.
Xi'an Jiaotong University · CNMemorial Sloan Kettering Cancer Center · USNantong University · CN

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
National Natural Science Foundation of China 51903201NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

It is of utmost urgency to achieve effective and safe anticancer treatment with the increasing mortality rate of cancer. Novel anticancer drugs and strategies need to be designed for enhanced therapeutic efficacy. Fenton- and Fenton-like reaction-based chemodynamic therapy (CDT) are new strategies to enhance anticancer efficacy due to their capacity to generate reactive oxygen species (ROS) and oxygen (O

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorDrug Therapy, CombinationHumansHypoxiaImmunotherapyNanostructuresNeoplasmsOxygenPhotochemotherapyPrecision MedicineReactive Oxygen SpeciesTumor MicroenvironmentAntineoplastic AgentsOxygenReactive Oxygen SpeciesChemodynamic therapyCombination therapyFenton reactionHypoxiaTheranostics

Identifiers

PMID34183023
PMCPMC8240398
OpenAlexW3177235705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.